ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ILMN Illumina Inc

138.15
-0.53 (-0.38%)
Last Updated: 11:40:19
Delayed by 15 minutes

Period:

Draw Mode:

Volume 292,202
Bid Price 138.10
Ask Price 138.24
News -
Day High 140.07

Low
89.00

52 Week Range

High
233.42

Day Low 136.29
Company Name Stock Ticker Symbol Market Type
Illumina Inc ILMN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.53 -0.38% 138.15 11:40:19
Open Price Low Price High Price Close Price Prev Close
138.68 136.29 140.07 138.68
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
7,751 292,202 $ 138.27 $ 40,404,164 - 89.00 - 233.42
Last Trade Time Type Quantity Stock Price Currency
11:40:25 4 $ 138.18 USD

Illumina (ILMN) Options Flow Summary

Overall Flow

Bearish

Net Premium

-717k

Calls / Puts

62.50%

Buys / Sells

62.50%

OTM / ITM

116.67%

Sweeps Ratio

0.00%

Illumina Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
22.15B 158.90M - 4.5B -1.16B -7.31 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Illumina News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ILMN Message Board. Create One! See More Posts on ILMN Message Board See More Message Board Posts

Historical ILMN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week140.71144.1899132.77136.421,265,516-2.56-1.82%
1 Month143.97146.08125.82134.391,631,734-5.82-4.04%
3 Months128.67148.19125.82137.841,790,1429.487.37%
6 Months130.41148.1989.00123.372,191,7667.745.94%
1 Year217.78233.4289.00149.241,829,491-79.63-36.56%
3 Years401.50526.0089.00225.911,368,222-263.35-65.59%
5 Years304.15555.7789.00261.591,269,885-166.00-54.58%

Illumina Description

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Your Recent History

Delayed Upgrade Clock